Encompass Health Co. (NYSE:EHC) Holdings Lifted by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC grew its position in Encompass Health Co. (NYSE:EHC) by 5.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 11,357 shares of the company’s stock after purchasing an additional 597 shares during the period. Janney Montgomery Scott LLC’s holdings in Encompass Health were worth $1,098,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. UMB Bank n.a. boosted its stake in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares during the period. V Square Quantitative Management LLC raised its holdings in Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after acquiring an additional 140 shares during the period. Oakworth Capital Inc. bought a new position in Encompass Health in the 2nd quarter worth $40,000. Benjamin F. Edwards & Company Inc. raised its holdings in Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after acquiring an additional 198 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Encompass Health during the 2nd quarter worth about $58,000. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Price Performance

Shares of EHC stock opened at $98.84 on Friday. Encompass Health Co. has a 1-year low of $63.59 and a 1-year high of $104.55. The company has a market cap of $9.96 billion, a P/E ratio of 23.87, a PEG ratio of 1.36 and a beta of 0.88. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The stock’s 50-day moving average is $96.38 and its 200 day moving average is $90.25.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The firm’s revenue for the quarter was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.86 earnings per share. Research analysts predict that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health announced that its Board of Directors has approved a share buyback plan on Wednesday, July 24th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to buy up to 5.4% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s leadership believes its shares are undervalued.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.69%. Encompass Health’s dividend payout ratio is presently 16.43%.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Truist Financial restated a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. KeyCorp upped their target price on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. UBS Group increased their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research report on Wednesday, September 25th. Stephens restated an “overweight” rating and set a $105.00 target price on shares of Encompass Health in a report on Tuesday, August 6th. Finally, Royal Bank of Canada increased their price target on shares of Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Nine research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.